AMANDEEP CHAHAL: Open Payments
NPI 1659019354 · RIPON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 24 payments from 9 companies in 2025. Trend: 2023 $460 · 2024 $481 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $191 |
| Amgen Inc. | 4 | $75 |
| Lilly USA, LLC | 2 | $55 |
| ABBVIE INC. | 2 | $40 |
| SANOFI PASTEUR INC. | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: AIRSUPRA, BREZTRI, EVENITY, QULIPTA, REXULTI, MOUNJARO, ZEPBOUND, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE.
Industry payments across CA — which companies pay providers there.
